Cargando…
COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices
OBJECTIVE: To describe the current status of COVID-19 vaccine guidelines. STUDY DESIGN AND SETTING: We searched databases, Google and guideline platforms to retrieve COVID-19 vaccine guidelines published between January 1, 2020 and July 8, 2021. We worked in pairs to identify the eligible guidelines...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669940/ https://www.ncbi.nlm.nih.gov/pubmed/34920115 http://dx.doi.org/10.1016/j.jclinepi.2021.12.015 |
_version_ | 1784614875086979072 |
---|---|
author | Wang, Zijun Liu, Hui Li, Yang Luo, Xufei Yang, Nan Lv, Meng Zhou, Qi Li, Qinyuan Wang, Ling Zhao, Junxian Liu, Yunlan Su, Renfeng Wu, Shouyuan Liu, Xiao Zhao, Siya Shi, Qianling Estill, Janne Liu, Xingrong Zhang, Wenhong Chen, Yaolong |
author_facet | Wang, Zijun Liu, Hui Li, Yang Luo, Xufei Yang, Nan Lv, Meng Zhou, Qi Li, Qinyuan Wang, Ling Zhao, Junxian Liu, Yunlan Su, Renfeng Wu, Shouyuan Liu, Xiao Zhao, Siya Shi, Qianling Estill, Janne Liu, Xingrong Zhang, Wenhong Chen, Yaolong |
author_sort | Wang, Zijun |
collection | PubMed |
description | OBJECTIVE: To describe the current status of COVID-19 vaccine guidelines. STUDY DESIGN AND SETTING: We searched databases, Google and guideline platforms to retrieve COVID-19 vaccine guidelines published between January 1, 2020 and July 8, 2021. We worked in pairs to identify the eligible guidelines and extract data of whether the methodology, funding, and conflict of interests were assessed/reported, and so on. Results were presented descriptively. RESULTS: A total of 106 COVID-19 vaccine guidelines were included. In the first half of 2021, on average 15 guidelines were published every month. Fifty (47.2%) guidelines addressed the vaccination of people with specific medical conditions, and 18 (17.0%) guidelines focused on adverse effects after vaccination. Only 28 (26.4%) guidelines reported the methodology they used. Four (3.8%) of guidelines assessed both the quality of evidence and strength of recommendations; 42 (39.6%) and 65 (61.3%) guidelines reported their funding sources and conflict of interest, respectively. Most guidelines were published in English (n = 92, 86.8%). CONCLUSION: A high number of guidelines on COVID-19 vaccines have been published in the recent months, but most of them lack clear and transparent reporting of methodology, funding, and conflicts of interest. Rigorous methodological and reporting quality evaluation of these guidelines is needed. |
format | Online Article Text |
id | pubmed-8669940 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Author(s). Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86699402021-12-14 COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices Wang, Zijun Liu, Hui Li, Yang Luo, Xufei Yang, Nan Lv, Meng Zhou, Qi Li, Qinyuan Wang, Ling Zhao, Junxian Liu, Yunlan Su, Renfeng Wu, Shouyuan Liu, Xiao Zhao, Siya Shi, Qianling Estill, Janne Liu, Xingrong Zhang, Wenhong Chen, Yaolong J Clin Epidemiol Original Article OBJECTIVE: To describe the current status of COVID-19 vaccine guidelines. STUDY DESIGN AND SETTING: We searched databases, Google and guideline platforms to retrieve COVID-19 vaccine guidelines published between January 1, 2020 and July 8, 2021. We worked in pairs to identify the eligible guidelines and extract data of whether the methodology, funding, and conflict of interests were assessed/reported, and so on. Results were presented descriptively. RESULTS: A total of 106 COVID-19 vaccine guidelines were included. In the first half of 2021, on average 15 guidelines were published every month. Fifty (47.2%) guidelines addressed the vaccination of people with specific medical conditions, and 18 (17.0%) guidelines focused on adverse effects after vaccination. Only 28 (26.4%) guidelines reported the methodology they used. Four (3.8%) of guidelines assessed both the quality of evidence and strength of recommendations; 42 (39.6%) and 65 (61.3%) guidelines reported their funding sources and conflict of interest, respectively. Most guidelines were published in English (n = 92, 86.8%). CONCLUSION: A high number of guidelines on COVID-19 vaccines have been published in the recent months, but most of them lack clear and transparent reporting of methodology, funding, and conflicts of interest. Rigorous methodological and reporting quality evaluation of these guidelines is needed. The Author(s). Published by Elsevier Inc. 2022-04 2021-12-14 /pmc/articles/PMC8669940/ /pubmed/34920115 http://dx.doi.org/10.1016/j.jclinepi.2021.12.015 Text en © 2021 The Author(s). Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Wang, Zijun Liu, Hui Li, Yang Luo, Xufei Yang, Nan Lv, Meng Zhou, Qi Li, Qinyuan Wang, Ling Zhao, Junxian Liu, Yunlan Su, Renfeng Wu, Shouyuan Liu, Xiao Zhao, Siya Shi, Qianling Estill, Janne Liu, Xingrong Zhang, Wenhong Chen, Yaolong COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices |
title | COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices |
title_full | COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices |
title_fullStr | COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices |
title_full_unstemmed | COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices |
title_short | COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices |
title_sort | covid-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669940/ https://www.ncbi.nlm.nih.gov/pubmed/34920115 http://dx.doi.org/10.1016/j.jclinepi.2021.12.015 |
work_keys_str_mv | AT wangzijun covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT liuhui covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT liyang covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT luoxufei covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT yangnan covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT lvmeng covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT zhouqi covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT liqinyuan covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT wangling covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT zhaojunxian covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT liuyunlan covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT surenfeng covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT wushouyuan covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT liuxiao covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT zhaosiya covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT shiqianling covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT estilljanne covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT liuxingrong covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT zhangwenhong covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices AT chenyaolong covid19vaccineguidelineswasnumerousinquantitybutmanylacktransparentreportingofmethodologicalpractices |